AstraZeneca Pharma gains ahead of board meet for 'Strategy Plan'

A special meeting of the board of directors of the company will be held today, to consider the 'Strategy Plan' for the company.

India has rallied 6% to Rs 843 in early noon deals on BSE ahead of its board meeting today to consider a “Strategy Plan” for the company.

“A special meeting of the board of directors of the company will be held on May 06, to consider the 'Strategy Plan' for the company,” AstraZeneca Pharma India said in a regulatory filing.

On March 5, the company informed the exchanges that the promoter shareholder of the company — AstraZeneca Pharmaceuticals AB Sweden — had notified its decision to reduce its shareholding in the company in order to comply with the requirement of minimum public shareholding norms.

As per the norms stipulated by Sebi, privately promoted companies are expected to have public shareholding at 25% by June 2013.

As of March 31, the promoters held a 90% stake in the company. FIIs held 0.01% stake, while the remaining holdings are with non institutional investors and bodies corporate.

Meanwhile, the stock has rallied 13.3% in past two trading sessions compared to 0.54% fall in benchmark Sensex, after the pharmaceutical company said its net losses almost halved to Rs 18.58 crore for the quarter ended March 2013 due to lower staff cost. The company had loss of Rs 33.01 crore in a year ago quarter.

The stock opened at Rs 810 and hit a high of Rs 849 on NSE. A combined around 187,000 shares changed hands on the counter till 1119 hours on NSE and BSE.
 

image
Business Standard
177 22
Business Standard

AstraZeneca Pharma gains ahead of board meet for 'Strategy Plan'

A special meeting of the board of directors of the company will be held today, to consider the 'Strategy Plan' for the company.

SI Reporter  |  Mumbai 

India has rallied 6% to Rs 843 in early noon deals on BSE ahead of its board meeting today to consider a “Strategy Plan” for the company.

“A special meeting of the board of directors of the company will be held on May 06, to consider the 'Strategy Plan' for the company,” AstraZeneca Pharma India said in a regulatory filing.

On March 5, the company informed the exchanges that the promoter shareholder of the company — AstraZeneca Pharmaceuticals AB Sweden — had notified its decision to reduce its shareholding in the company in order to comply with the requirement of minimum public shareholding norms.

As per the norms stipulated by Sebi, privately promoted companies are expected to have public shareholding at 25% by June 2013.

As of March 31, the promoters held a 90% stake in the company. FIIs held 0.01% stake, while the remaining holdings are with non institutional investors and bodies corporate.

Meanwhile, the stock has rallied 13.3% in past two trading sessions compared to 0.54% fall in benchmark Sensex, after the pharmaceutical company said its net losses almost halved to Rs 18.58 crore for the quarter ended March 2013 due to lower staff cost. The company had loss of Rs 33.01 crore in a year ago quarter.

The stock opened at Rs 810 and hit a high of Rs 849 on NSE. A combined around 187,000 shares changed hands on the counter till 1119 hours on NSE and BSE.
 

RECOMMENDED FOR YOU

AstraZeneca Pharma gains ahead of board meet for 'Strategy Plan'

A special meeting of the board of directors of the company will be held today, to consider the 'Strategy Plan' for the company.

A special meeting of the board of directors of the company will be held today, to consider the 'Strategy Plan' for the company.
India has rallied 6% to Rs 843 in early noon deals on BSE ahead of its board meeting today to consider a “Strategy Plan” for the company.

“A special meeting of the board of directors of the company will be held on May 06, to consider the 'Strategy Plan' for the company,” AstraZeneca Pharma India said in a regulatory filing.

On March 5, the company informed the exchanges that the promoter shareholder of the company — AstraZeneca Pharmaceuticals AB Sweden — had notified its decision to reduce its shareholding in the company in order to comply with the requirement of minimum public shareholding norms.

As per the norms stipulated by Sebi, privately promoted companies are expected to have public shareholding at 25% by June 2013.

As of March 31, the promoters held a 90% stake in the company. FIIs held 0.01% stake, while the remaining holdings are with non institutional investors and bodies corporate.

Meanwhile, the stock has rallied 13.3% in past two trading sessions compared to 0.54% fall in benchmark Sensex, after the pharmaceutical company said its net losses almost halved to Rs 18.58 crore for the quarter ended March 2013 due to lower staff cost. The company had loss of Rs 33.01 crore in a year ago quarter.

The stock opened at Rs 810 and hit a high of Rs 849 on NSE. A combined around 187,000 shares changed hands on the counter till 1119 hours on NSE and BSE.
 
image
Business Standard
177 22

LIVE MARKET

BSE

  ( %)

NSE

  ( %)

Widgets Magazine

More News

STOCK WATCH

Company Price() Chg(%)
H P C L 930.90 9.81
Finolex Cables 334.05 9.43
B P C L 1010.85 9.12
Prestige Estates 184.75 8.84
Lycos Internet 18.95 7.67
> More on BSE Gainers
Company Price() Chg(%)
Finolex Cables 337.00 10.20
H P C L 931.65 9.65
B P C L 1012.00 9.19
Prestige Estates 184.20 8.29
Reliance Power 52.25 7.40
> More on NSE Gainers
Company Price() Chg(%)
Novartis India 724.80 -12.45
Vaibhav Global 267.80 -6.15
Fortis Health. 164.05 -5.56
R C F 43.05 -5.49
Essel Propack 184.25 -4.41
> More on BSE Gainers
Company Price() Chg(%)
R C F 43.05 -5.38
Fortis Health. 164.00 -5.28
VRL Logistics 276.80 -4.83
Vaibhav Global 267.70 -4.77
Ruchi Soya Inds. 22.20 -4.72
> More on NSE Gainers
Widgets Magazine
Widgets Magazine
Widgets Magazine

Derivatives

Index
Instrument Type
Expiry Date
Option Type
Strike Price

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard